Stockscreener 앱 받기
2.63
6.05%
0.15
시간 외 거래:
2.62
-0.010
-0.38%
Accendra Health Inc 주식(ACH)의 최신 뉴스
OMI.N News & Events - Intellectia AI
OMI.N Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
ACH SEC FilingsAccendra Health Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Accendra Health (ACH) details 2025 results, home-care focus and pay votes in 2026 proxy - stocktitan.net
Kevin M. Webb reports 5.61% stake in Accendra Health (NASDAQ: ACH) - Stock Titan
Owens & Minor Appoints Colin Bain as Chief Products Officer, Effective March 30, 2026 - MarketScreener
ACH Stock Price, News & Analysis | Accendra Health - Stock Titan
Vanguard disaggregates holdings; Accendra Health (ACH) listed as 0 shares in amendment - Stock Titan
Accendra Health (ACH) CEO surrenders shares to cover RSU tax obligations - Stock Titan
Accendra Health (ACH) CFO surrenders 11,286 shares for tax withholding - Stock Titan
Accendra Health (ACH) COO surrenders shares for tax withholding, retains stake - stocktitan.net
Accendra Health (ACH) EVP uses 9,347 shares to cover tax withholding - Stock Titan
OMI SEC FilingsOwens & Minor 10-K, 10-Q, 8-K Forms - Stock Titan
Tranche Update on Accendra Health, Inc.'s Equity Buyback Plan announced on February 28, 2025. - marketscreener.com
Fitch Maintains Accendra Health's Rating Watches; Withdraws Ratings - MarketScreener
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
Is the Options Market Signaling a Surge in Accendra Health Shares? - Bitget
OMI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Accendra Health CFO granted 85,067 restricted shares | ACH Insider Trading - Stock Titan
ACH Technical Analysis & Stock Price Forecast - Intellectia AI
Owens & Minor, Inc. (OMI) Stock Analysis: Is The 94% Potential Upside Worth The Risk? - directorstalkinterviews.com
Owens & Minor, Inc. (NYSE:OMI) Q4 2025 Earnings Call Transcript - Insider Monkey
Accendra Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:ACH) 2026-02-25 - Seeking Alpha
Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32 - Nasdaq
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Insider Monkey
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com Canada
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com South Africa
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bicara Therapeutics Inc. (BCAX), Accendra Health (ACH) and Travere Therapeutics (TVTX) - The Globe and Mail
MSN Money - MSN
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus
Accendra Health bets on Optum contract, leaner structure - HME News
Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News
Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Accendra Health reports Q4 adjusted EPS 21c, consensus 22c - TipRanks
Accendra Health Posts 2025 Results, Guides 2026 Outlook - TipRanks
Accendra Health Reports Fourth Quarter 2025 Financial Results - marketscreener.com
Earnings Scheduled For February 19, 2026 - Benzinga
Q4 2025 Accendra Health Inc Earnings Call Transcript - GuruFocus
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
ACH Financials: Income Statement, Balance Sheet & Cash Flow | Accendra Health Inc - Stock Titan
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
3.97%
자본화:
|
볼륨(24시간):